Asymmetry Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,152,098
| Closed | -$3.56M | – | 46 |
|
|
2020
Q4 | $3.56M | Buy |
5,152,098
+3,591,771
| +230% | +$2.48M | 1.62% | 24 |
|
|
2020
Q3 | $3.51M | Sell |
1,560,327
-1,997,719
| -56% | -$4.5M | 2.26% | 19 |
|
|
2020
Q2 | $12.7M | Buy |
3,558,046
+1,173,559
| +49% | +$4.2M | 9.76% | 1 |
|
|
2020
Q1 | $9.06M | Buy |
2,384,487
+1,968,556
| +473% | +$7.48M | 9.91% | 2 |
|
|
2019
Q4 | $1.25M | Buy |
+415,931
| New | +$1.25M | 2.24% | 20 |
|